![]() |
市场调查报告书
商品编码
2009340
行动伽马摄影机市场规模、份额、趋势和预测:按产品、应用、最终用户和地区划分,2026-2034年Mobile Gamma Cameras Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 |
||||||
2025年全球行动伽马摄影机市场规模为5,970万美元。展望未来,IMARC集团预测,该市场将在2026年至2034年间以3.26%的复合年增长率成长,到2034年达到8,040万美元。目前,北美市场占据主导地位,预计2025年市占率将超过35%。推动北美市场成长的因素包括:医疗影像技术的进步、慢性病盛行率的上升、对携带式诊断设备需求的成长、肿瘤学和心臟病学领域应用范围的扩大,以及政府的医疗保健支援措施。
行动式伽马摄影机市场的发展主要受癌症和心血管疾病发生率上升的推动。这些设备需求量很大,因为它们携带式,可用于医疗中心的门诊和重症监护室。此外,与传统伽马摄影机相比,它们具有更高的柔软性,使其适用于各种临床环境。
诊断成像技术的进步,例如空间解析度的提高以及诊断成像与数位系统的融合,发挥着至关重要的作用。此外,老年人口的不断增长,以及老年人患有慢性疾病的高风险,也推动了对高效便捷的诊断方法的需求。
美国正崛起为行动式伽马摄影机的主要市场。随着癌症和心血管疾病等慢性病的盛行率上升,携带式伽马摄影机的应用日益广泛,因为这些疾病需要早期准确诊断才能进行有效治疗。便携式伽玛相机凭藉其移动性和易用性,可在包括门诊和急诊在内的各种医疗机构中使用。此外,人们日益认识到核医学在诊断方面的潜力,以及高解析度和软体整合等技术的进步,也是推动市场成长的因素。美国人口老化加剧了慢性病的发生率,这也进一步刺激了对移动式伽马摄影机的需求。这项技术的特性使政府和医疗机构能够专注于更具成本效益的诊断方法。政府主导的各项措施正在进一步加速先进医学影像技术的发展,这对市场至关重要。
慢性病盛行率增加
慢性病日益普遍是推动该市场成长的主要因素。根据世界卫生组织(WHO)统计,非传染性疾病(NCDs)每年导致4,100万人死亡,占全球死亡总数的74%。此外,癌症发生率的上升以及放射导引手术中对伽马摄影机设备需求的显着增长也推动了全球产品需求。世界卫生组织指出,癌症是全球主要死因之一,2020年约有1,000万人死于癌症,约占全球死亡总数的六分之一。因此,核子医学扫描术诊断等医学影像技术的不断进步以及固态技术的出现对市场产生了积极影响。医疗设备小型化的趋势是推动市场成长的另一个重要因素。此外,全球医疗保健支出的成长也促进了市场成长。推动携带式伽马摄影机市场成长的其他因素包括:公众可支配收入的增加、产品认知度的提高、医疗领域的显着进步以及主要企业开展的大量研发活动。
技术进步
成像技术的进步已被证明在推动行动伽马摄影机市场发展方面发挥着至关重要的作用。现代伽马摄影机具有更高的解析度、便携性和先进的资料处理能力,能够产生精准的诊断影像。固体检测器、高能量准直器和软体整合等创新技术彻底革新了该领域,有望实现更高品质的影像和更快的诊断速度。所有这些都支持微创诊断技术的日益普及,尤其是在肿瘤学和心臟病学等领域,早期准确诊断至关重要。此外,整合的人工智慧 (AI) 和机器学习功能可实现即时影像分析,从而提高诊断准确性。医疗机构正越来越多地采用这项技术来提高营运效率,并应对与患者预后、误诊和工作流程管理相关的健康挑战。随着持续的研发投入以及先进成像技术在更多医疗机构的应用,这项技术仍然是支撑行动伽马摄影机市场成长的基石。
向可携式和即时护理解决方案过渡
医疗产业转向携带式和即时诊断解决方案的转变是推动行动伽马摄影机市场发展的另一个关键因素。传统的伽马摄影机通常固定安装,需要专用的成像室,这限制了其应用范围。而移动式伽马摄影机则具有柔软性,可在病患床边、门诊甚至急诊室进行诊断影像。这种移动性对于加护病房和行动不便的患者尤其重要。此外,降低医疗成本和提高营运效率的日益重视也加速了携带式影像解决方案的普及。移动式伽马摄影机还能将先进的诊断能力带到患者身边,尤其是在农村和资源匮乏的地区,从而支持分散式医疗模式。无需大规模基础设施即可进行即时诊断的能力符合当前的医疗保健趋势,使得行动伽马摄影机在已开发市场和开发中国家市场都越来越具有吸引力。
The global mobile gamma cameras market size was valued at USD 59.7 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 80.4 Million by 2034, exhibiting a CAGR of 3.26% from 2026-2034. North America currently dominates the market, holding a market share of over 35.0% in 2025. The advancements in medical imaging technology, rising prevalence of chronic diseases, increasing demand for portable diagnostic devices, growing adoption in oncology and cardiology applications, and supportive government healthcare initiatives are some of the factors driving the market in North America.
The market for mobile gamma cameras is supported by the growing incidence of cancer and cardiovascular disease. The increased demand for these devices is increasing as they are portable for use in an outpatient facility or a centralized site at the health care center. It is also more flexible than traditional gamma cameras for providing service in different clinical settings.
Improvements in imaging modalities have an important role, such as improvements in spatial resolution and integrating the imaging modalities with digital systems. Moreover, the increase in the elderly population, which is known as a high-risk group for developing chronic disease conditions, encourages the demand for efficient and simply available diagnostics.
The United States has emerged as a key region for mobile gamma cameras. The increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, that require an early and accurate diagnosis for better management, is increasing the use of portable gamma cameras. It will give them mobility and ease of handling to be used in different types of healthcare facilities, including outpatient and emergency departments. Another factor is the recognized potential of nuclear medicine with regard to diagnosis, alongside advances such as higher resolution and software integration. Moreover, the elderly population of the U.S. drives high demand for mobile gamma cameras due to their vulnerability to chronic diseases. The nature of the technology has made it possible for government and health service providers to focus on cost-effective diagnostic measures while further driving the pushes into advanced medical imaging technologies by government initiatives, which are essential boosts in the favor of the market.
Increasing prevalence of chronic diseases
The market is driven by the increasing prevalence of chronic diseases. According to the WHO, noncommunicable diseases (NCDs) are responsible for 41 Million deaths annually, accounting for 74% of all global fatalities. Besides this, the growing incidences of cancer and a considerable rise in the requirement for gamma camera devices during radio-guided surgery are driving the product demand on the global level. As per the WHO, cancer ranks among the leading causes of death globally, claiming approximately 10 Million lives in 2020, which is about 1 in every 6 deaths. In line with this, continual technological advancements in medical imaging options, such as nuclear imaging and the emergence of solid-state technology, are positively impacting the market. The growing trend of miniaturization of medical devices is acting as another significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure across the globe. Some of the other factors that are providing an impetus to the mobile gamma cameras market growth include the inflating disposable incomes of the masses, the rising product awareness, significant improvements in the healthcare sector and extensive research and development (R&D) activities conducted by key players.
Technological advancements
Advancements in imaging technology have proven to be instrumental in driving the market for mobile gamma cameras. Modern gamma cameras offer enhanced resolution, the ability to carry them from one point to another, and sophisticated data processing that helps produce precise diagnostic imaging. Innovative technologies like solid-state detectors, high-energy collimators, software integration have revolutionized the field with their promises of better image quality and rapid results. All of these things support the growing inclination toward minimally invasive diagnostic techniques, especially in oncology and cardiology, where early and accurate identification is imperative. Moreover, artificial intelligence and machine learning embedded into the system act as real-time interpreters of images to improve diagnosis accuracy. Healthcare service providers are increasingly embracing the technology to enhance operational efficiency and solve the health problems related to patient outcome improvement, diagnostic errors, and workflow management. With continued research and development efforts, technology remains the foundation for most growth within the mobile gamma cameras market as it takes advanced imaging technology to more healthcare option venues.
Shift toward portable and point-of-care solutions
The healthcare industry's shift toward portable and point-of-care diagnostic solutions is another key factor driving the mobile gamma cameras market. Traditional gamma cameras are often stationary and require dedicated imaging suites, limiting their accessibility. Mobile gamma cameras, however, offer flexibility, enabling imaging at the patient's bedside, in outpatient settings, or in emergency scenarios. This mobility is particularly valuable in critical care units and for patients with mobility constraints. Moreover, the growing emphasis on reducing healthcare costs and improving operational efficiency is accelerating the adoption of portable imaging solutions. Mobile gamma cameras also support decentralized healthcare models by bringing advanced diagnostic capabilities closer to patients, especially in rural or resource-limited settings. The ability to perform real-time diagnostics without extensive infrastructure requirements aligns with current healthcare trends, making mobile gamma cameras an increasingly attractive choice for both developed and developing markets.
Single-head mobile gamma cameras hold the largest mobile gamma cameras market share of 62.9% in 2025. This is due to their cost-effectiveness, versatility, and widespread adoption in various clinical applications. These systems are significantly less expensive than dual- or triple-head cameras, making them an economical choice for small to mid-sized healthcare facilities, especially in resource-constrained settings. The affordability of single-head units allows hospitals and diagnostic centers to invest in nuclear imaging technology without substantial capital expenditure. Moreover, single-head cameras are highly versatile, catering to a broad range of diagnostic needs, including thyroid scans, bone scintigraphy, renal imaging, and cardiac studies. Their portability and compact design make them ideal for point-of-care settings, enabling bedside imaging and use in outpatient clinics, emergency rooms, and rural healthcare centers.
Thyroid scanning dominates the market due to its critical role in diagnosing and monitoring thyroid disorders, which are increasingly prevalent worldwide. Conditions such as hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer necessitate accurate imaging for effective management. Mobile gamma cameras, equipped with advanced nuclear imaging capabilities, provide precise visualization of thyroid gland function and structure by detecting the uptake of radioactive isotopes like iodine-123 or technetium-99m. The portability of these cameras enhances accessibility, making thyroid scanning feasible in outpatient settings, rural areas, and point-of-care environments. This is particularly crucial as thyroid disorders are often underdiagnosed, especially in regions with limited healthcare infrastructure. Furthermore, the non-invasive and cost-effective nature of thyroid scans aligns with the increasing demand for affordable diagnostic solutions.
In 2025, hospitals hold the largest market share with 41.3% share due to their extensive infrastructure, large patient volume, and diverse diagnostic requirements. As primary centers for healthcare delivery, hospitals frequently manage complex and critical cases, including oncology, cardiology, and neurology, where gamma imaging is crucial for diagnosis, treatment planning, and monitoring. The availability of skilled professionals, such as nuclear medicine specialists and radiologists, further supports the widespread use of these devices in hospital settings. Moreover, hospitals often have greater financial capacity to invest in advanced diagnostic equipment like mobile gamma cameras.
In 2025 North America leads the market with 35.0% share. Some of the factors include advanced health care infrastructure, increased health care expenditure, and the speedy adoption of modern medical technologies. The well-established hospitals and diagnostic centers in the region are equipped with state-of-the-art imaging facilities to provide accurate treatment and diagnosis, hence creating a great need to acquire mobile gamma cameras. North America has the highest prevalence of chronic diseases, for instance, cancer and cardiovascular disorders, which compels the need for new advanced diagnostic tools like gamma cameras. The aging population of the region also necessitates the increased use of these portable imaging solutions for elderly patients who undergo frequent routine diagnostic assessments but may find it difficult to go to a hospital or facility.
UNITED STATES MOBILE GAMMA CAMERAS MARKET ANALYSIS
In 2025, the United States accounts for 83.9% of mobile gamma cameras market in North America. The market in the United States is driven by the increasing prevalence of chronic diseases, with an estimated 129 Million people affected by at least one major chronic condition, such as heart disease, cancer, diabetes, obesity, or hypertension, as defined by the US Department of Health and Human Services. This growing burden of disease has led to higher demand for advanced diagnostic imaging technologies. Mobile gamma cameras offer the flexibility to be used across various healthcare settings, including hospitals, clinics, and remote locations, improving access to diagnostic services for patients. Additionally, technological advancements in mobile gamma cameras, such as improved image resolution and faster scanning capabilities, are contributing to market growth. The push for cost-effective healthcare solutions further drives the adoption of mobile imaging systems, as they reduce the need for expensive fixed infrastructure. Favorable reimbursement policies for nuclear medicine procedures and the growing awareness of early disease detection and personalized treatment are also expected to support market expansion. Furthermore, the demand for mobile gamma cameras is anticipated to rise as early diagnosis and treatment of chronic conditions become increasingly prioritized in healthcare systems.
ASIA PACIFIC MOBILE GAMMA CAMERAS MARKET ANALYSIS
The mobile gamma cameras market in the Asia Pacific (APAC) region is experiencing growth due to the rising prevalence of chronic diseases and respiratory infections. According to PubMed Central, respiratory infections alone account for 475,000 deaths, representing 16.8% of total deaths in the region. Chronic conditions such as cancer, cardiovascular diseases, and diabetes are also on the rise, particularly in countries like China, India, and Japan. Mobile gamma cameras offer a vital solution, providing flexible diagnostic options in hospitals, outpatient clinics, and remote areas where healthcare access is limited. Government investments in healthcare infrastructure and increasing awareness of the benefits of early disease detection are expected to drive the demand for these mobile systems. Furthermore, advancements in technology, making mobile gamma cameras more affordable and efficient, contribute to their growing adoption across APAC.
EUROPE MOBILE GAMMA CAMERAS MARKET ANALYSIS
In Europe, the mobile gamma cameras market is growing due to the rising prevalence of chronic diseases, which are becoming more prominent in an aging population. As of January, 2023, the EU population was estimated at 448.8 Million, with more than one-fifth (21.3%) aged 65 years and over, according to Eurostat. This demographic shift is leading to an increase in age-related chronic conditions such as cancer, cardiovascular diseases, and neurological disorders, which drive the demand for advanced diagnostic tools. Mobile gamma cameras provide flexible solutions for hospitals, outpatient clinics, and remote healthcare facilities, especially in rural areas where access to fixed imaging infrastructure is limited. The ability to conduct imaging on-site offers cost-effective healthcare alternatives, which is particularly important in light of Europe's strained healthcare budgets. Moreover, advancements in technology, including improved image resolution and faster scanning capabilities, further boost market growth. With increasing government investments in healthcare infrastructure and the push for personalized medicine, mobile gamma cameras are becoming an essential tool in early disease detection and monitoring across the region.
LATIN AMERICA MOBILE GAMMA CAMERAS MARKET ANALYSIS
The mobile gamma cameras market in Latin America is expanding due to the increasing burden of chronic diseases, with Brazil estimating 928,000 deaths annually from chronic conditions such as heart disease, diabetes, and cancer, according to PubMed Central. This rising mortality rate drives the need for advanced diagnostic tools. Additionally, limited access to healthcare in rural areas creates demand for portable imaging solutions. Government efforts to improve healthcare infrastructure, along with the growing adoption of mobile health technologies, further support market growth. Mobile gamma cameras offer a cost-effective and accessible alternative for early disease detection in the region.
MIDDLE EAST AND AFRICA MOBILE GAMMA CAMERAS MARKET ANALYSIS
The mobile gamma cameras market in the Middle East and Africa is growing due to the increasing demand for advanced healthcare solutions, particularly in the UAE, Saudi Arabia, and South Africa. These regions have strong investments in healthcare infrastructure, and mobile gamma cameras offer a flexible and scalable solution to expand diagnostic services. For instance, according to the World Economic Forum, healthcare expenditure in the Gulf Cooperation Council (GCC) is predicted to reach USD 135.5 Billion by 2027. Mobile gamma cameras provide portable, cost-effective alternatives to traditional imaging methods, improving access to healthcare in remote areas. Government efforts to expand healthcare infrastructure further support market growth in the region.
Key players are focusing on developing innovative and advanced mobile gamma cameras to meet the growing demand for precision and portability in diagnostic imaging. They are incorporating features such as solid-state detectors, improved energy resolution, and artificial intelligence (AI)-powered imaging software to improve diagnostic efficiency and accuracy . Companies are also designing compact, lightweight, and user-friendly models to cater to point-of-care applications, ensuring wider adoption across diverse healthcare settings. These advancements allow market leaders to differentiate their products and appeal to a broader customer base. Moreover, collaborations with hospitals, research institutions, and nuclear medicine centers are enabling key players to expand their market presence and access new opportunities. Partnerships with technology providers help integrate cutting-edge software and data analytics capabilities into gamma camera systems. Additionally, collaborations with healthcare providers foster trust and brand loyalty, ensuring a steady demand for their products.